Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Clinical trial NCT03124459 · TERMINATED
Trial details
- NCT number
- NCT03124459
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2020-03-11
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.